酸酸乳ssr网站

指纹app下载vnp-快连加速器app

酸酸乳免费SS/SSR节点账号及链接分享-每日福利(2021/4/27 ...:2021-4-27 · 说明：每日福利-免费ssr节点双账号众及ss节点链接同时共享，ssr节点账号及链接更新于2021年4月27日12时38分。此酸酸乳节点账号有效期不定，此香港节点账号延迟低，速度比之前的快一些。本站所分享的资源节点仅是帮助大家科学上网在Google上查 ...

Read more

指纹app下载vnp-快连加速器app

We are in the pre-clinical phases of a new paradigm for the treatment of Pulmonary Arterial Hypertension (PAH), addressing the underlying causes of the disease.

酸酸乳节点分享网站
ssr节点2022每日更新

指纹app下载vnp-快连加速器app

There is a pressing unmet need for more effective treatments of Pulmonary Arterial Hypertension. A progressive disease caused by cell proliferation in lung blood vessels, PAH (high blood pressure in lung arteries) can adversely affect the heart.
More

指纹app下载vnp-快连加速器app

We have developed a new class of inhalable drugs to decrease cell proliferation, instead of merely “relaxing” pulmonary arteries as today’s vasodilators do. Our hope after clinical trials is to prove greater efficacy with fewer side effects.
More
酸酸乳节点网站

指纹app下载vnp-快连加速器app

In solving the unique problems of our own pulmonary drug research, Pulmokine has developed patented inhalation systems and preclinical efficacy solutions that we are making available to the pulmonary drug development community.
酸酸乳节点网站

指纹app下载vnp-快连加速器app

Pulmokine is interested in strategic partnerships with leading pharmaceutical corporations, R&D firms, licensors and/or investors to take our breakthrough technologies into the next phases of clinical development.
Contact us

© 2013 Pulmokine. All Rights Reserved.
A pharmaceutical company developing new treatments for Pulmonary Hypertension.
突突加速器官网,梯子npv加速,51虚拟机x8加速插件,十大免费加速器  免费机场最新版,免费机场破解版,免费机场跑路了,免费机场打不开了  小狐狸的小窝官网,小狐狸的小窝npv,小狐狸的小窝免费永久加速,小狐狸的小窝7天试用  非凡加速器ios下载,非凡加速器mac下载,非凡加速器用不了了,非凡加速器vps  拇指猴跑路了,拇指猴打不开,拇指猴2024,拇指猴vqn  飞轮加速器破解版,飞轮加速器npv,飞轮加速器vqn,飞轮加速器7天试用